The DOI matches its Crossref record; 193 of the 193 references it cites were found in a registry or an index.
Combinational strategy for high-performance cancer chemotherapy
Abstract
The clinical outcomes of conventional mono-chemotherapy of cancers are usually far from satisfactory due to some issues such as tumor heterogeneity and resistance to chemotherapeutic drugs. With the increasing knowledge of molecular signal pathways and pathological mechanisms involved in the initiation and progression of cancers, collaborative strategies have been elaborated to optimize therapeutic outcomes. This review surveys the most recent advances in combination therapy including combination chemotherapy, chemotherapy plus gene therapy, chemotherapy plus phototherapy, as well as chemotherapy plus immunotherapy. Additionally, chemotherapy-involved multiple therapy that merges various therapeutic modalities is also presented. We try to elicit the rationales of applying these combinational formulations for cancer chemotherapy, which might provide new guidelines for high-performance cancer treatments.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Siegel, R. L., Miller, K. D., & Jemal, A. (2018) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21442 · Cited by 16,579
Oncology meets immunology: the cancer-immunity cycle.
Chen, D. S., & Mellman, I. (2013) · Immunity · doi:10.1016/j.immuni.2013.07.012 · Cited by 6,929
The future of immune checkpoint therapy
Sharma, P., & Allison, J. P. (2015) · Science · doi:10.1126/science.aaa8172 · Cited by 4,878
Toll-like receptor control of the adaptive immune responses
Iwasaki, A., & Medzhitov, R. (2004) · Nature Immunology · doi:10.1038/ni1112 · Cited by 4,193
Cetuximab and Chemotherapy as Initial Treatment for Metastatic Colorectal Cancer
Van Cutsem, E., Köhne, C.-H., Hitre, E., Zaluski, J., Chang Chien, C.-R., Makhson, A., D'Haens, G., Pintér, T., Lim, R., Bodoky, G., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0805019 · Cited by 3,877
Upconversion Nanoparticles: Design, Nanochemistry, and Applications in Theranostics
Chen, G., Qiu, H., Prasad, P. N., & Chen, X. (2014) · Chemical Reviews · doi:10.1021/cr400425h · Cited by 2,699
The causes and consequences of genetic heterogeneity in cancer evolution
Burrell, R. A., McGranahan, N., Bartek, J., & Swanton, C. (2013) · Nature · doi:10.1038/nature12625 · Cited by 2,262
Delivery materials for siRNA therapeutics
Kanasty, R., Dorkin, J. R., Vegas, A., & Anderson, D. (2013) · Nature Materials · doi:10.1038/nmat3765 · Cited by 1,800
Overcoming the Achilles' heel of photodynamic therapy
Fan, W., Huang, P., & Chen, X. (2016) · Chemical Society Reviews · doi:10.1039/c6cs00616g · Cited by 1,684
Muller, P. A. J., & Vousden, K. H. (2013) · Nature Cell Biology · doi:10.1038/ncb2641 · Cited by 1,647
Pujade-Lauraine, E., Hilpert, F., Weber, B., Reuss, A., Poveda, A., Kristensen, G., Sorio, R., Vergote, I., Witteveen, P., Bamias, A., et al. (2014) · Journal of Clinical Oncology · doi:10.1200/jco.2013.51.4489 · Cited by 1,622
Muller, A. J., DuHadaway, J. B., Donover, P. S., Sutanto-Ward, E., & Prendergast, G. C. (2005) · Nature Medicine · doi:10.1038/nm1196 · Cited by 1,064
Chen, Q., Feng, L., Liu, J., Zhu, W., Dong, Z., Wu, Y., & Liu, Z. (2016) · Advanced Materials · doi:10.1002/adma.201601902 · Cited by 1,034
Chen, W., Ouyang, J., Liu, H., Chen, M., Zeng, K., Sheng, J., Liu, Z., Han, Y., Wang, L., Li, J., et al. (2017) · Advanced Materials · doi:10.1002/adma.201603864 · Cited by 1,027
Dai, Y., Xu, C., Sun, X., & Chen, X. (2017) · Chemical Society Reviews · doi:10.1039/c6cs00592f · Cited by 931
He, C., Lu, K., Liu, D., & Lin, W. (2014) · Journal of the American Chemical Society · doi:10.1021/ja4098862 · Cited by 885
Li, S.-Y., Cheng, H., Xie, B.-R., Qiu, W.-X., Zeng, J.-Y., Li, C.-X., Wan, S.-S., Zhang, L., Liu, W.-L., & Zhang, X.-Z. (2017) · ACS Nano · doi:10.1021/acsnano.7b02533 · Cited by 780
Self-citationSocinski, M. A., Bondarenko, I., Karaseva, N. A., Makhson, A. M., Vynnychenko, I., Okamoto, I., Hon, J. K., Hirsh, V., Bhar, P., Zhang, H., et al. (2012) · Journal of Clinical Oncology · doi:10.1200/jco.2011.39.5848 · Cited by 756
Thirty years of BCL-2: translating cell death discoveries into novel cancer therapies
Delbridge, A. R. D., Grabow, S., Strasser, A., & Vaux, D. L. (2016) · Nature Reviews Cancer · doi:10.1038/nrc.2015.17 · Cited by 752
Akt-Mediated Regulation of Autophagy and Tumorigenesis Through Beclin 1 Phosphorylation
Wang, R. C., Wei, Y., An, Z., Zou, Z., Xiao, G., Bhagat, G., White, M., Reichelt, J., & Levine, B. (2012) · Science · doi:10.1126/science.1225967 · Cited by 728 · cited 1×
“11 [170] Y. Liu, L. Qiao, S. Zhang, G. Wan, B. Chen, P. Zhou, N. Zhang, Y. Wang, 12 Dual pH-responsive multifunctional nanoparticles for targeted treatment of 13 breast cancer by combining immunotherapy and chemotherapy, Acta Biomater.”
Huang, P., Wang, D., Su, Y., Huang, W., Zhou, Y., Cui, D., Zhu, X., & Yan, D. (2014) · Journal of the American Chemical Society · doi:10.1021/ja505212y · Cited by 716
Chen, A. M., Zhang, M., Wei, D., Stueber, D., Taratula, O., Minko, T., & He, H. (2009) · Small · doi:10.1002/smll.200900621 · Cited by 671
Immune parameters affecting the efficacy of chemotherapeutic regimens
Zitvogel, L., Kepp, O., & Kroemer, G. (2011) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2010.223 · Cited by 669
Song, M., Liu, T., Shi, C., Zhang, X., & Chen, X. (2016) · ACS Nano · doi:10.1021/acsnano.5b06779 · Cited by 662
Self-citationWang, Y., Gao, S., Ye, W.-H., Yoon, H. S., & Yang, Y.-Y. (2006) · Nature Materials · doi:10.1038/nmat1737 · Cited by 658
Palmer, A. C., & Sorger, P. K. (2017) · Cell · doi:10.1016/j.cell.2017.11.009 · Cited by 642
Recent advances of cocktail chemotherapy by combination drug delivery systems
Hu, Q., Sun, W., Wang, C., & Gu, Z. (2016) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2015.10.022 · Cited by 625
Gao, M., Liang, C., Song, X., Chen, Q., Jin, Q., Wang, C., & Liu, Z. (2017) · Advanced Materials · doi:10.1002/adma.201701429 · Cited by 590
Shen, Y., Jin, E., Zhang, B., Murphy, C. J., Sui, M., Zhao, J., Wang, J., Tang, J., Fan, M., Van Kirk, E., et al. (2010) · Journal of the American Chemical Society · doi:10.1021/ja909475m · Cited by 565
The EGFR as a target for anticancer therapy—focus on cetuximab
Baselga, J. (2001) · European Journal of Cancer · doi:10.1016/s0959-8049(01)00233-7 · Cited by 563
Glycosylated Porphyrins, Phthalocyanines, and Other Porphyrinoids for Diagnostics and Therapeutics
Singh, S., Aggarwal, A., Bhupathiraju, N. V. S. D. K., Arianna, G., Tiwari, K., & Drain, C. M. (2015) · Chemical Reviews · doi:10.1021/acs.chemrev.5b00244 · Cited by 563
Mechanism for the endocytosis of spherical nucleic acid nanoparticle conjugates
Choi, C. H. J., Hao, L., Narayan, S. P., Auyeung, E., & Mirkin, C. A. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1305804110 · Cited by 533
Drug self-delivery systems for cancer therapy
Qin, S.-Y., Zhang, A.-Q., Cheng, S.-X., Rong, L., & Zhang, X.-Z. (2017) · Biomaterials · doi:10.1016/j.biomaterials.2016.10.016 · Cited by 532
Self-citationWang, Y., Wang, K., Zhao, J., Liu, X., Bu, J., Yan, X., & Huang, R. (2013) · Journal of the American Chemical Society · doi:10.1021/ja312221g · Cited by 527
Deng, X., Cao, M., Zhang, J., Hu, K., Yin, Z., Zhou, Z., Xiao, X., Yang, Y., Sheng, W., Wu, Y., et al. (2014) · Biomaterials · doi:10.1016/j.biomaterials.2014.02.006 · Cited by 511
Kemp, J. A., Shim, M. S., Heo, C. Y., & Kwon, Y. J. (2016) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2015.10.019 · Cited by 506
ADVANCED DIFFUSE HISTIOCYTIC LYMPHOMA, A POTENTIALLY CURABLE DISEASE
Devita, V., Canellos, G., Chabner, B., Schein, P., Hubbard, S., & Young, R. (1975) · The Lancet · doi:10.1016/s0140-6736(75)91142-3 · Cited by 484
Tumor-Expressed IDO Recruits and Activates MDSCs in a Treg-Dependent Manner
Holmgaard, R. B., Zamarin, D., Li, Y., Gasmi, B., Munn, D. H., Allison, J. P., Merghoub, T., & Wolchok, J. D. (2015) · Cell Reports · doi:10.1016/j.celrep.2015.08.077 · Cited by 482
Exploiting the curative potential of adoptive T‐cell therapy for cancer
Hinrichs, C. S., & Rosenberg, S. A. (2014) · Immunological Reviews · doi:10.1111/imr.12132 · Cited by 466
Wang, Y., Xie, Y., Li, J., Peng, Z.-H., Sheinin, Y., Zhou, J., & Oupický, D. (2017) · ACS Nano · doi:10.1021/acsnano.6b08731 · Cited by 461
Ramakrishnan, R., Assudani, D., Nagaraj, S., Hunter, T., Cho, H.-I., Antonia, S., Altiok, S., Celis, E., & Gabrilovich, D. I. (2010) · Journal of Clinical Investigation · doi:10.1172/jci40269 · Cited by 460
Conde, J., Oliva, N., Zhang, Y., & Artzi, N. (2016) · Nature Materials · doi:10.1038/nmat4707 · Cited by 449
Meng, H., Wang, M., Liu, H., Liu, X., Situ, A., Wu, B., Ji, Z., Chang, C. H., & Nel, A. E. (2015) · ACS Nano · doi:10.1021/acsnano.5b00510 · Cited by 440
Chemophototherapy: An Emerging Treatment Option for Solid Tumors
Luo, D., Carter, K. A., Miranda, D., & Lovell, J. F. (2017) · Advanced Science · doi:10.1002/advs.201600106 · Cited by 436
Liu, Y., Liu, Y., Bu, W., Cheng, C., Zuo, C., Xiao, Q., Sun, Y., Ni, D., Zhang, C., Liu, J., et al. (2015) · Angewandte Chemie International Edition · doi:10.1002/anie.201500478 · Cited by 425
Clinical experiences with systemically administered siRNA-based therapeutics in cancer
Zuckerman, J. E., & Davis, M. E. (2015) · Nature Reviews Drug Discovery · doi:10.1038/nrd4685 · Cited by 424
Feng, L., Cheng, L., Dong, Z., Tao, D., Barnhart, T. E., Cai, W., Chen, M., & Liu, Z. (2017) · ACS Nano · doi:10.1021/acsnano.6b07525 · Cited by 424
Nanomedicine of synergistic drug combinations for cancer therapy – Strategies and perspectives
Zhang, R. X., Wong, H. L., Xue, H. Y., Eoh, J. Y., & Wu, X. Y. (2016) · Journal of Controlled Release · doi:10.1016/j.jconrel.2016.06.012 · Cited by 380
Evaluation of Combination Chemotherapy
Zhao, L., Wientjes, M. G., & Au, J. L.-S. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-1087 · Cited by 379
Huang, C.-C., Chia, W.-T., Chung, M.-F., Lin, K.-J., Hsiao, C.-W., Jin, C., Lim, W.-H., Chen, C.-C., & Sung, H.-W. (2016) · Journal of the American Chemical Society · doi:10.1021/jacs.6b01784 · Cited by 372
Liao, L., Liu, J., Dreaden, E. C., Morton, S. W., Shopsowitz, K. E., Hammond, P. T., & Johnson, J. A. (2014) · Journal of the American Chemical Society · doi:10.1021/ja502011g · Cited by 362
Chen, W., Zeng, K., Liu, H., Ouyang, J., Wang, L., Liu, Y., Wang, H., Deng, L., & Liu, Y. (2017) · Advanced Functional Materials · doi:10.1002/adfm.201605795 · Cited by 353
Sun, H., Su, J., Meng, Q., Yin, Q., Chen, L., Gu, W., Zhang, Z., Yu, H., Zhang, P., Wang, S., et al. (2017) · Advanced Functional Materials · doi:10.1002/adfm.201604300 · Cited by 352
The initial clinical trial of nitrogen mustard
Gilman, A. (1963) · The American Journal of Surgery · doi:10.1016/0002-9610(63)90232-0 · Cited by 338
An O2 Self‐Sufficient Biomimetic Nanoplatform for Highly Specific and Efficient Photodynamic Therapy
Cheng, H., Zhu, J., Li, S., Zeng, J., Lei, Q., Chen, K., Zhang, C., & Zhang, X. (2016) · Advanced Functional Materials · doi:10.1002/adfm.201603212 · Cited by 335
Self-citationWang, T., Wang, D., Yu, H., Wang, M., Liu, J., Feng, B., Zhou, F., Yin, Q., Zhang, Z., Huang, Y., et al. (2016) · ACS Nano · doi:10.1021/acsnano.5b07706 · Cited by 295
Supramolecular “Trojan Horse” for Nuclear Delivery of Dual Anticancer Drugs
Cai, Y., Shen, H., Zhan, J., Lin, M., Dai, L., Ren, C., Shi, Y., Liu, J., Gao, J., & Yang, Z. (2017) · Journal of the American Chemical Society · doi:10.1021/jacs.6b12322 · Cited by 293
The EGFR-specific antibody cetuximab combined with chemotherapy triggers immunogenic cell death
Pozzi, C., Cuomo, A., Spadoni, I., Magni, E., Silvola, A., Conte, A., Sigismund, S., Ravenda, P. S., Bonaldi, T., Zampino, M. G., et al. (2016) · Nature Medicine · doi:10.1038/nm.4078 · Cited by 292
Cell-to-cell variation in p53 dynamics leads to fractional killing.
Paek, A. L., Liu, J. C., Loewer, A., Forrester, W. C., & Lahav, G. (2016) · Cell · doi:10.1016/j.cell.2016.03.025 · Cited by 292
Arlen, P. M., Gulley, J. L., Parker, C., Skarupa, L., Pazdur, M., Panicali, D., Beetham, P., Tsang, K. Y., Grosenbach, D. W., Feldman, J., et al. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-2059 · Cited by 287
Therapeutic Cancer Vaccines: Current Status and Moving Forward
Schlom, J. (2012) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djs033 · Cited by 282
Wu, M., Meng, Q., Chen, Y., Zhang, L., Li, M., Cai, X., Li, Y., Yu, P., Zhang, L., & Shi, J. (2016) · Advanced Materials · doi:10.1002/adma.201505524 · Cited by 274
Zhang, Y., Yang, C., Wang, W., Liu, J., Liu, Q., Huang, F., Chu, L., Gao, H., Li, C., Kong, D., et al. (2016) · Scientific Reports · doi:10.1038/srep21225 · Cited by 273
Devulapally, R., Sekar, N. M., Sekar, T. V., Foygel, K., Massoud, T. F., Willmann, J. K., & Paulmurugan, R. (2015) · ACS Nano · doi:10.1021/nn507465d · Cited by 260
Li, S.-Y., Cheng, H., Qiu, W.-X., Zhang, L., Wan, S.-S., Zeng, J.-Y., & Zhang, X.-Z. (2017) · Biomaterials · doi:10.1016/j.biomaterials.2017.07.026 · Cited by 260
Self-citationCancer Cell Membrane‐Biomimetic Oxygen Nanocarrier for Breaking Hypoxia‐Induced Chemoresistance
Tian, H., Luo, Z., Liu, L., Zheng, M., Chen, Z., Ma, A., Liang, R., Han, Z., Lu, C., & Cai, L. (2017) · Advanced Functional Materials · doi:10.1002/adfm.201703197 · Cited by 243
Chemoimmunotherapy: Reengineering Tumor Immunity
Chen, G., & Emens, L. A. (2013) · Cancer Immunology, Immunotherapy · doi:10.1007/s00262-012-1388-0 · Cited by 242
Liu, L., Zhang, Y., Qiu, W., Zhang, L., Gao, F., Li, B., Xu, L., Fan, J., Li, Z., & Zhang, X. (2017) · Small · doi:10.1002/smll.201701621 · Cited by 240
Self-citationCo-delivery of drugs and plasmid DNA for cancer therapy
Teo, P. Y., Cheng, W., Hedrick, J. L., & Yang, Y. Y. (2016) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2015.10.014 · Cited by 229
Liu, Y., Qiao, L., Zhang, S., Wan, G., Chen, B., Zhou, P., Zhang, N., & Wang, Y. (2018) · Acta Biomaterialia · doi:10.1016/j.actbio.2017.11.010 · Cited by 218
Zheng, C., Zheng, M., Gong, P., Deng, J., Yi, H., Zhang, P., Zhang, Y., Liu, P., Ma, Y., & Cai, L. (2013) · Biomaterials · doi:10.1016/j.biomaterials.2013.01.053 · Cited by 200
Dual-pore mesoporous carbon@silica composite core-shell nanospheres for multidrug delivery
Fang, Y., Zheng, G., Yang, J., Tang, H., Zhang, Y., Kong, B., Lv, Y., Xu, C., Asiri, A. M., Zi, J., et al. (2014) · Angewandte Chemie International Edition · doi:10.1002/anie.201402002 · Cited by 198
An immunostimulatory dual-functional nanocarrier that improves cancer immunochemotherapy
Chen, Y., Xia, R., Huang, Y., Zhao, W., Li, J., Zhang, X., Wang, P., Venkataramanan, R., Fan, J., Xie, W., et al. (2016) · Nature Communications · doi:10.1038/ncomms13443 · Cited by 190
Self-citationChen, W.-H., Luo, G.-F., Qiu, W.-X., Lei, Q., Liu, L.-H., Wang, S.-B., & Zhang, X.-Z. (2017) · Biomaterials · doi:10.1016/j.biomaterials.2016.11.057 · Cited by 190
Self-citationShao, L., Zhang, R., Lu, J., Zhao, C., Deng, X., & Wu, Y. (2017) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.6b11209 · Cited by 190
Recent Developments in Cancer Vaccines
Palucka, K., Ueno, H., & Banchereau, J. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.0902539 · Cited by 189
Hu, Y.-L., Jahangiri, A., DeLay, M., & Aghi, M. K. (2012) · Cancer Research · doi:10.1158/0008-5472.can-12-1076 · Cited by 188
Low dose cyclophosphamide: Mechanisms of T cell modulation
Madondo, M. T., Quinn, M., & Plebanski, M. (2016) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2015.11.005 · Cited by 188
Blurring the Role of Oligonucleotides: Spherical Nucleic Acids as a Drug Delivery Vehicle
Tan, X., Lu, X., Jia, F., Liu, X., Sun, Y., Logan, J. K., & Zhang, K. (2016) · Journal of the American Chemical Society · doi:10.1021/jacs.6b07554 · Cited by 184
Initiator‐Loaded Gold Nanocages as a Light‐Induced Free‐Radical Generator for Cancer Therapy
Wang, X., Gao, F., & Zhang, X. (2017) · Angewandte Chemie International Edition · doi:10.1002/anie.201703159 · Cited by 183
Self-citationMiao, L., Guo, S., Zhang, J., Kim, W. Y., & Huang, L. (2014) · Advanced Functional Materials · doi:10.1002/adfm.201401076 · Cited by 177
Liu, L., Qiu, W., Li, B., Zhang, C., Sun, L., Wan, S., Rong, L., & Zhang, X. (2016) · Advanced Functional Materials · doi:10.1002/adfm.201602541 · Cited by 177
Self-citationSu, J., Sun, H., Meng, Q., Yin, Q., Zhang, P., Zhang, Z., Yu, H., & Li, Y. (2016) · Advanced Functional Materials · doi:10.1002/adfm.201603381 · Cited by 177
Liu, W., Wang, Y.-M., Li, Y.-H., Cai, S.-J., Yin, X.-B., He, X.-W., & Zhang, Y.-K. (2017) · Small · doi:10.1002/smll.201603459 · Cited by 175
Chen, G., Jaskula‐Sztul, R., Esquibel, C. R., Lou, I., Zheng, Q., Dammalapati, A., Harrison, A., Eliceiri, K. W., Tang, W., Chen, H., et al. (2017) · Advanced Functional Materials · doi:10.1002/adfm.201604671 · Cited by 174
Wang, H., Mukherjee, S., Yi, J., Banerjee, P., Chen, Q., & Zhou, S. (2017) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.7b06062 · Cited by 170
Liang, X., Gao, C., Cui, L., Wang, S., Wang, J., & Dai, Z. (2017) · Advanced Materials · doi:10.1002/adma.201703135 · Cited by 169
Luo, G., Chen, W., Lei, Q., Qiu, W., Liu, Y., Cheng, Y., & Zhang, X. (2016) · Advanced Functional Materials · doi:10.1002/adfm.201505175 · Cited by 168
Self-citationPan, H., Liu, L., & Cai, L. (2022) · Biomaterial Engineering · doi:10.1007/978-981-16-5419-0_18 · Cited by 165
Awuah, S. G., Zheng, Y.-R., Bruno, P. M., Hemann, M. T., & Lippard, S. J. (2015) · Journal of the American Chemical Society · doi:10.1021/jacs.5b10182 · Cited by 164
Saraswathy, M., & Gong, S. (2014) · Materials Today · doi:10.1016/j.mattod.2014.05.002 · Cited by 163
Lei, Q., Qiu, W., Hu, J., Cao, P., Zhu, C., Cheng, H., & Zhang, X. (2016) · Small · doi:10.1002/smll.201601137 · Cited by 163
Self-citationMitochondria-targeting “Nanoheater” for enhanced photothermal/chemo-therapy
Chen, S., Lei, Q., Qiu, W.-X., Liu, L.-H., Zheng, D.-W., Fan, J.-X., Rong, L., Sun, Y.-X., & Zhang, X.-Z. (2017) · Biomaterials · doi:10.1016/j.biomaterials.2016.11.056 · Cited by 163
Self-citationAn overview of the effective combination therapies for the treatment of breast cancer
Núñez, C., Capelo, J. L., Igrejas, G., Alfonso, A., Botana, L. M., & Lodeiro, C. (2016) · Biomaterials · doi:10.1016/j.biomaterials.2016.04.027 · Cited by 162
Mittal, A., Chitkara, D., Behrman, S. W., & Mahato, R. I. (2014) · Biomaterials · doi:10.1016/j.biomaterials.2014.04.053 · Cited by 161
Chen, W., Yuan, Y., Cheng, D., Chen, J., Wang, L., & Shuai, X. (2014) · Small · doi:10.1002/smll.201303951 · Cited by 160
Zhang, Q., Shen, C., Zhao, N., & Xu, F. (2017) · Advanced Functional Materials · doi:10.1002/adfm.201606229 · Cited by 160
Stimuli-Responsive “Cluster Bomb” for Programmed Tumor Therapy
Lei, Q., Wang, S.-B., Hu, J.-J., Lin, Y.-X., Zhu, C.-H., Rong, L., & Zhang, X.-Z. (2017) · ACS Nano · doi:10.1021/acsnano.7b03088 · Cited by 160
Self-citationWu, H., Jin, H., Wang, C., Zhang, Z., Ruan, H., Sun, L., Yang, C., Li, Y., Qin, W., & Wang, C. (2017) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.6b16844 · Cited by 159
Zhao, F., Yin, H. Y., & Li, J. (2013) · Biomaterials · doi:10.1016/j.biomaterials.2013.10.044 · Cited by 158
Dose-Dense Chemotherapy Improves Mechanisms of Antitumor Immune Response
Chang, C.-L., Hsu, Y.-T., Wu, C.-C., Lai, Y.-Z., Wang, C., Yang, Y.-C., Wu, T.-C., & Hung, C.-F. (2013) · Cancer Research · doi:10.1158/0008-5472.can-12-2225 · Cited by 158
Dai, X., & Tan, C. (2014) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2014.09.010 · Cited by 155
Liu, D., Zhang, H., Mäkilä, E. M., Fan, J., Herranz‐Blanco, B., Wang, C., Rosa, R. F., Ribeiro, A. J., Salonen, J., Hirvonen, J. J., et al. (2014) · Biomaterials · doi:10.1016/j.biomaterials.2014.10.079 · Cited by 152
Lesterhuis, W. J., Salmons, J., Nowak, A. K., Rozali, E. N., Khong, A., Dick, I. M., Harken, J. A., Robinson, B. W. S., & Lake, R. (2013) · PLoS ONE · doi:10.1371/journal.pone.0061895 · Cited by 152
Cai, L., Xu, G., Shi, C., Guo, D., Wang, X., & Luo, J. (2015) · Biomaterials · doi:10.1016/j.biomaterials.2014.10.044 · Cited by 151
Wei, X., Wang, Y., Xiong, X., Guo, X., Zhang, L., Zhang, X., & Zhou, S. (2016) · Advanced Functional Materials · doi:10.1002/adfm.201603336 · Cited by 151
Self-citationSasso, M. S., Lollo, G., Pitorre, M., Solito, S., Pinton, L., Valpione, S., Bastiat, G., Mandruzzato, S., Bronte, V., Marigo, I., et al. (2016) · Biomaterials · doi:10.1016/j.biomaterials.2016.04.010 · Cited by 150
Luo, L., Bian, Y., Liu, Y., Zhang, X., Wang, M., Xing, S., Li, L., & Gao, D. (2016) · Small · doi:10.1002/smll.201503961 · Cited by 145
Self-citationTao, Y., Ju, E., Liu, Z., Dong, K., Ren, J., & Qu, X. (2014) · Biomaterials · doi:10.1016/j.biomaterials.2014.04.073 · Cited by 143
Hirsh, V., Paz-Ares, L. G., Boyer, M. J., Rosell, R., Middleton, G., Eberhardt, W., Szczęsna, A., Reiterer, P., Saleh, M. N., Arrieta, O. G., et al. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2010.32.8971 · Cited by 141
Du, X. C., Zhao, C., Zhou, M., Ma, T., Huang, H., Jaroniec, M., Zhang, X., & Qiao, S. (2016) · Small · doi:10.1002/smll.201602592 · Cited by 140
Self-citationZhou, M., Liu, S., Jiang, Y., Ma, H., Shi, M., Wang, Q., Zhong, W., Liao, W., & Xing, M. M. Q. (2015) · Advanced Functional Materials · doi:10.1002/adfm.201501434 · Cited by 137
He, C., Poon, C. J., Chan, C., Yamada, S. D., & Lin, W. (2016) · Journal of the American Chemical Society · doi:10.1021/jacs.6b02486 · Cited by 136
Sun, L., Wang, D., Chen, Y., Wang, L., Huang, P., Li, Y., Liu, Z., Yao, H., & Shi, J. (2017) · Biomaterials · doi:10.1016/j.biomaterials.2017.04.028 · Cited by 136
Wen, Y. F., Zhang, W., Gong, N., Wang, Y., Guo, H., Guo, W., Wang, P. C., & Liang, X. (2017) · Nanoscale · doi:10.1039/c7nr03129g · Cited by 135
Carrier-free functionalized multidrug nanorods for synergistic cancer therapy
Zhou, M., Zhang, X., Yang, Y., Liu, Z., Tian, B., Jie, J., & Zhang, X. (2013) · Biomaterials · doi:10.1016/j.biomaterials.2013.07.080 · Cited by 134
Self-citationPramod, P. S., Takamura, K., Chaphekar, S., Balasubramanian, N., & Jayakannan, M. (2012) · Biomacromolecules · doi:10.1021/bm301583s · Cited by 132
Su, S., Tian, Y., Li, Y., Ding, Y., Ji, T., Wu, M.-Y., Wu, Y. F., & Nie, G. (2015) · ACS Nano · doi:10.1021/nn505729m · Cited by 132
Cittelly, D. M., Dimitrova, I. K., Howe, E. N., Cochrane, D. R., Jean, A., Spoelstra, N. S., Post, M. D., Lu, X. J. D., Broaddus, R. R., Spillman, M. A., et al. (2012) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-12-0463 · Cited by 131
Combinatorial prospects of nano-targeted chemoimmunotherapy
Silva, C. G. D., Rueda, F., Löwik, C. W. G. M., OSSENDORP, F. A., & Cruz, L. J. (2016) · Biomaterials · doi:10.1016/j.biomaterials.2016.01.006 · Cited by 131
Huang, S., Duan, S., Wang, J., Bao, S., Qiu, X., Li, C., Liu, Y., Yan, L., Zhang, Z., & Hu, Y. (2016) · Advanced Functional Materials · doi:10.1002/adfm.201504912 · Cited by 131
Vicari, A. P., Luu, R., Zhang, N., Patel, S., Makinen, S. R., Hanson, D. C., Weeratna, R. D., & Krieg, A. Μ. (2008) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-008-0586-2 · Cited by 130
Manegold, C., van Zandwijk, N., Szczęsna, A., Zatloukal, P., Au, J. S. K., Błasińska-Morawiec, M., Serwatowski, P., Krzakowski, M. J., Jassem, J., Tan, E. H., et al. (2011) · Annals of Oncology · doi:10.1093/annonc/mdr030 · Cited by 130
Li, J., Wei, K., Zuo, S., Xu, Y., Zha, Z., Ke, W., Chen, H., & Ge, Z. (2017) · Advanced Functional Materials · doi:10.1002/adfm.201702108 · Cited by 126
Noh, I., Kim, H., Choi, J., Choi, Y., Lee, D. K., Huh, Y., & Haam, S. (2015) · Biomaterials · doi:10.1016/j.biomaterials.2015.03.006 · Cited by 121
Yu, C., Qian, L., Ge, J., Fu, J., Yuan, P., Yao, S. C. L., & Yao, S. Q. (2016) · Angewandte Chemie International Edition · doi:10.1002/anie.201602188 · Cited by 121
Xu, C., Wang, P., Zhang, J., Tian, H., Park, K., & Chen, X. (2015) · Small · doi:10.1002/smll.201501034 · Cited by 120
Yin, F., Yang, C., Wang, Q., Zeng, S., Hu, R., Lin, G., Tian, J., Hu, S., Lan, R. F., Yoon, H. S., et al. (2015) · Theranostics · doi:10.7150/thno.11335 · Cited by 120
Ma, Y., Fan, X., & Li, L. (2015) · Carbohydrate Polymers · doi:10.1016/j.carbpol.2015.10.050 · Cited by 114
Barua, S., & Mitragotri, S. (2013) · ACS Nano · doi:10.1021/nn403913k · Cited by 109
A theranostic micelleplex co-delivering SN-38 and VEGF siRNA for colorectal cancer therapy
Lee, S., Yang, C., Peng, C., Wei, M., Chen, K.-C., Yao, C.-J., & Shieh, M. (2016) · Biomaterials · doi:10.1016/j.biomaterials.2016.01.068 · Cited by 107
Lamb, L. S., Bowersock, J., Dasgupta, A., Gillespie, G. Y., Su, Y. Y., Johnson, A., & Spencer, H. T. (2013) · PLoS ONE · doi:10.1371/journal.pone.0051805 · Cited by 104
miR-34c may protect lung cancer cells from paclitaxel-induced apoptosis
Catuogno, S., Cerchia, L., Romano, G., Pognonec, P., Condorelli, G., & de Franciscis, V. (2012) · Oncogene · doi:10.1038/onc.2012.51 · Cited by 103
Devulapally, R., Foygel, K., Sekar, T. V., Willmann, J. K., & Paulmurugan, R. (2016) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.6b08153 · Cited by 103
Yu, C., Zhou, M., Zhang, X., Wei, W., Chen, X., & Zhang, X. (2015) · Nanoscale · doi:10.1039/c5nr00290g · Cited by 100
Self-citationZhou, F., Feng, B., Wang, T., Wang, D., Meng, Q., Zeng, J., Zhang, Z., Wang, S., Yu, H., & Li, Y. (2017) · Advanced Functional Materials · doi:10.1002/adfm.201606530 · Cited by 100
Tuning the Drug Loading and Release of DNA‐Assembled Gold‐Nanorod Superstructures
Raeesi, V., Chou, L. Y. T., & Chan, W. C. W. (2016) · Advanced Materials · doi:10.1002/adma.201600773 · Cited by 97
Polymer assembly: Promising carriers as co-delivery systems for cancer therapy
Li, N., Zhao, L., Qi, L., Li, Z., & Luan, Y. (2015) · Progress in Polymer Science · doi:10.1016/j.progpolymsci.2015.10.009 · Cited by 96
Ma, W., Guo, Q., Li, Y., Wang, X., Wang, J., & Tu, P. (2016) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2016.11.033 · Cited by 96
Yao, C., Liu, J., Wu, X., Tai, Z., Gao, Y., Zhu, Q., Li, J., Zhang, L., Hu, C., Gu, F., et al. (2016) · Journal of Controlled Release · doi:10.1016/j.jconrel.2016.04.034 · Cited by 94
Monk, B. J., Brady, M. F., Aghajanian, C. A., Lankes, H. A., Rizack, T., Leach, J. W., Fowler, J. M., Higgins, R. V., Hanjani, P., Morgan, M. A., et al. (2017) · Annals of Oncology · doi:10.1093/annonc/mdx049 · Cited by 94
Salzano, G., Costa, D. F. G., Sarısözen, C., Luther, E., Mattheolabakis, G., Pooja, P. D., & Torchilin, V. P. (2016) · Small · doi:10.1002/smll.201600925 · Cited by 92
Hu, F., Yuan, Y., Mao, D., Wu, W., & Liu, B. (2017) · Biomaterials · doi:10.1016/j.biomaterials.2017.08.018 · Cited by 92
Chen, F., Zhao, Y., Pan, Y., Xue, X., Zhang, X., Kumar, A., & Liang, X. (2015) · Molecular Pharmaceutics · doi:10.1021/mp500744m · Cited by 90
Self-citationXu, Q., Leong, J., Chua, Q. Y., Chi, Y. T., Chow, P. K. H., Pack, D. W., & Wang, C. (2013) · Biomaterials · doi:10.1016/j.biomaterials.2013.03.044 · Cited by 89
The challenges for cancer chemoprevention
Penny, L. K., & WALLACE, H. M. (2015) · Chemical Society Reviews · doi:10.1039/c5cs00705d · Cited by 88
Jia, H.-Z., Zhang, W., Zhu, J., Yang, B., Chen, S., Chen, G., Zhao, Y., Feng, J. X., & Zhang, X. (2015) · Journal of Controlled Release · doi:10.1016/j.jconrel.2015.08.006 · Cited by 88
Self-citationHu, S., Lee, E., Wang, C., Wang, J., Zhou, Z., Li, Y., Li, X., Tang, J., Lee, D. H., Liu, X., et al. (2015) · Journal of Controlled Release · doi:10.1016/j.jconrel.2015.10.031 · Cited by 86
Wang, K., Hu, Q., Zhu, W., Zhao, M., Yuan, P., & Tang, G. (2015) · Advanced Functional Materials · doi:10.1002/adfm.201403921 · Cited by 84
Maximizing Synergistic Activity When Combining RNAi and Platinum-Based Anticancer Agents
Xiao, H., Qi, R., Li, T., Awuah, S. G., Zheng, Y., Wei, W., Kang, X., Song, H., Wang, Y., Yu, Y., et al. (2017) · Journal of the American Chemical Society · doi:10.1021/jacs.6b12108 · Cited by 84
Anti-tumor Efficiency of Lipid-coated Cisplatin Nanoparticles Co-loaded with MicroRNA-375
Tan, Y., Zhao, P., Rong, Z., Li, B., Xue, H., You, J., He, C., Li, W., He, X., Lee, R. J., et al. (2015) · Theranostics · doi:10.7150/thno.13130 · Cited by 83
Alex, M. R. A., Nehate, C., Veeranarayanan, S., et al. (2017) · Biomaterials · doi:10.1016/j.biomaterials.2017.04.022 · Cited by 83
Fan, Y.-P., Liao, J., Lu, Y., Tian, D., Ye, F., Zhao, P., Xiang, G., Tang, W.-X., & He, X. (2017) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2017.03.010 · Cited by 82
Pentcheva‐Hoang, T., Simpson, T. R., Montalvo-Ortiz, W., & Allison, J. P. (2014) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-14-0104 · Cited by 80
Takwi, A., Wang, Y.-M., Wu, J., Michaelis, M., Cinatl, J., & Chen, T.-S. (2013) · Oncogene · doi:10.1038/onc.2013.330 · Cited by 79
Multifunctional Theranostic Nanoplatform for Cancer Combined Therapy Based on Gold Nanorods
Chen, W., Yang, C., Qiu, W., Luo, G., Jia, H., Lei, Q., Wang, X., Liu, G., Zhuo, R., & Zhang, X. (2015) · Advanced Healthcare Materials · doi:10.1002/adhm.201500453 · Cited by 78
Self-citationPeng, S., Lyford-Pike, S., Akpeng, B., Wu, A. A., Hung, C., Hannaman, D., Saunders, J. R., Wu, T. ‐., & Pai, S. I. (2012) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-012-1322-5 · Cited by 77
Wang, J., Ma, W., & Tu, P. (2015) · Macromolecular Bioscience · doi:10.1002/mabi.201500043 · Cited by 77
Li, Y., Wang, H., Wang, K., Hu, Q., Yao, Q. Z., Shen, Y., Yu, G., & Tang, G. (2016) · Small · doi:10.1002/smll.201602697 · Cited by 76
Teegala, L. R., Garikapati, K. R., Reddy, S. G., Reddy, B. V. S., Yadav, J. S., Bhadra, U., & Bhadra, M. P. (2016) · Scientific Reports · doi:10.1038/srep35223 · Cited by 76
Jang, E., Kim, E., Son, H. Y., Lim, E., Lee, H., Choi, Y., Park, K., Han, S., Suh, J., Huh, Y., et al. (2016) · Biomaterials · doi:10.1016/j.biomaterials.2016.07.036 · Cited by 73
Co-delivery of genes and drugs with nanostructured calcium carbonate for cancer therapy
Chen, S., Zhao, D., Li, F., Zhuo, R., & Cheng, S. (2012) · RSC Advances · doi:10.1039/c1ra00527h · Cited by 72
Kong, F., Zhang, H., Qu, X., Zhang, X., Chen, D., Ding, R., Mäkilä, E. M., Salonen, J., Santos, H. A., & Hai, M. (2016) · Advanced Materials · doi:10.1002/adma.201602763 · Cited by 72
Self-citationTheranostic GO‐Based Nanohybrid for Tumor Induced Imaging and Potential Combinational Tumor Therapy
Qin, S., Feng, J. X., Rong, L., Jia, H., Chen, S., Liu, X., Luo, G., Zhuo, R., & Zhang, X. (2013) · Small · doi:10.1002/smll.201301613 · Cited by 71
Self-citationRationally Designed 2-in-1 Nanoparticles Can Overcome Adaptive Resistance in Cancer
Goldman, A. J., Kulkarni, A. A., Kohandel, M., Pandey, P. R., Rao, P., Natarajan, S. K., Sabbisetti, V. S., & Sengupta, S. (2016) · ACS Nano · doi:10.1021/acsnano.6b00320 · Cited by 71
Seth, A., Heo, M. B., & Lim, Y. T. (2014) · Biomaterials · doi:10.1016/j.biomaterials.2014.05.076 · Cited by 70
Roy, A., Singh, M. S., Upadhyay, P. K., & Bhaskar, S. (2013) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2013.01.045 · Cited by 69
Hardwick, N. R., Frankel, P., Ruel, C., Kilpatrick, J., Tsai, W., Kos, F., Kaltcheva, T., Leong, L., Morgan, R., Chung, V., et al. (2018) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-17-2709 · Cited by 66
Yan, T., Li, D., Li, J., Cheng, F., Cheng, J., Huang, Y., & He, J. (2016) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2016.05.070 · Cited by 65
Camacho, K. M., Menegatti, S., Vogus, D. R., Pusuluri, A., Fuchs, Z., Jarvis, M., Zakrewsky, M., Evans, M. A., Chen, R., & Mitragotri, S. (2016) · Journal of Controlled Release · doi:10.1016/j.jconrel.2016.03.027 · Cited by 63
Ma, W., Su, H., Cheetham, A. G., Zhang, W., Wang, Y., Kan, Q., & Cui, H. (2017) · Journal of Controlled Release · doi:10.1016/j.jconrel.2017.01.015 · Cited by 61
Guo, D., Xu, S., Wang, N., Jiang, H., Huang, Y., Jin, X., Bai, X., Zhang, C., & Zhu, X. (2017) · Biomaterials · doi:10.1016/j.biomaterials.2017.08.032 · Cited by 60
Davoodi, P., Srinivasan, M. P., & Wang, C. (2016) · Acta Biomaterialia · doi:10.1016/j.actbio.2016.05.003 · Cited by 58
Polysaccharide nano-vesicular multidrug carriers for synergistic killing of cancer cells
Pramod, P. S., Shah, R., Chaphekar, S., Balasubramanian, N., & Jayakannan, M. (2014) · Nanoscale · doi:10.1039/c4nr03514c · Cited by 54
Deshpande, N. U., & Jayakannan, M. (2016) · Biomacromolecules · doi:10.1021/acs.biomac.6b01411 · Cited by 54
Cui, J., Li, L., Wang, C., Jin, H., Cheng, Y., Wang, Y., Li, D., Tian, H., Niu, C. S., Wang, G., et al. (2015) · Cytotherapy · doi:10.1016/j.jcyt.2015.03.605 · Cited by 51
Self-citationBarnes, J. C., Bruno, P. M., Nguyen, H. V. ‐., Liao, L., Liu, J., Hemann, M. T., & Johnson, J. A. (2016) · Journal of the American Chemical Society · doi:10.1021/jacs.6b06321 · Cited by 51
Chen, M., Zhang, Y., Chen, Z., Xie, S., Luo, X., & Li, X. (2016) · Acta Biomaterialia · doi:10.1016/j.actbio.2016.12.005 · Cited by 47
Yi, X., Zhao, D., Zhang, Q., Xu, J., Yuan, G., Zhuo, R., & Li, F. (2016) · Polymer Chemistry · doi:10.1039/c6py00900j · Cited by 46
Yi, H., Liu, L., Sheng, N., Li, P., Pan, H., Cai, L., & Ma, Y. (2016) · Biomacromolecules · doi:10.1021/acs.biomac.6b00141 · Cited by 45
Zhao, H., Wang, Y., Yu, J., Wei, F., Cao, S., Zhang, X., Dong, N., Li, H. Y., & Ren, X. (2016) · Clinical Colorectal Cancer · doi:10.1016/j.clcc.2016.02.005 · Cited by 44
Self-citationCytokine-induced killer cells as a feasible adoptive immunotherapy for the treatment of lung cancer
Chen, D., Sha, H., Hu, T., Dong, S., Zhang, J., Liu, S., Cao, H., Ma, R., Wu, Y. F., Jing, C., et al. (2018) · Cell Death and Disease · doi:10.1038/s41419-018-0404-5 · Cited by 44
Facile Approach To Construct Ternary Cocktail Nanoparticles for Cancer Combination Therapy
Huang, P., Ao, J., Zhou, L., Su, Y., Huang, W., Zhu, X., & Yan, D. (2016) · Bioconjugate Chemistry · doi:10.1021/acs.bioconjchem.6b00158 · Cited by 43
Fluorinated carbon fiber as a novel nanocarrier for cancer chemo-photothermal therapy
Sun, L., Gong, P., Liu, X., Pang, M., Tian, M., Chen, J., Du, J., & Liu, Z. (2017) · Journal of Materials Chemistry B · doi:10.1039/c7tb01155e · Cited by 40
Wang, Y., Chen, J. C., Liang, X., Han, H., Wang, H., Yang, Y., & Li, Q. (2017) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.7b00184 · Cited by 39
Huang, P., Hu, M., Zhou, L., Wang, Y., Pang, Y., Tong, G., Huang, W., Su, Y., & Zhu, X. (2015) · RSC Advances · doi:10.1039/c5ra16511c · Cited by 38
Li, Y., Song, L., Lin, J., Ma, J., Pan, Z., Zhang, Y., Su, G., Ye, S., Luo, F., Zhu, X., et al. (2017) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.7b08218 · Cited by 38
Sahu, N., Stéphan, J.-P., Cruz, D. D., Merchant, M. A., Haley, B., Bourgon, R., Classon, M., & Settleman, J. (2016) · Nature Communications · doi:10.1038/ncomms12351 · Cited by 37
Integrative Development of a TLR8 Agonist for Ovarian Cancer Chemoimmunotherapy
Monk, B. J., Facciabene, A., Brady, W. E., Aghajanian, C. A., Fracasso, P. M., Walker, J. L., Lankes, H. A., Manjarrez, K. L., Danet-Desnoyers, G.-A., Bell‐McGuinn, K. M., et al. (2016) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-16-1453 · Cited by 37
MicroRNAs and cancer resistance: A new molecular plot
Fanini, F., & Fabbri, M. (2016) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt.353 · Cited by 35
Qu, X., Felder, M. A. R., Horta, Z. P., Sondel, P. M., & Rakhmilevich, A. L. (2013) · International Immunopharmacology · doi:10.1016/j.intimp.2013.10.019 · Cited by 29
Vectorization of Nucleic Acids for Therapeutic Approach: Tutorial Review
Geinguenaud, F., Guénin, E., Lalatonne, Y., & Motte, L. (2016) · ACS Chemical Biology · doi:10.1021/acschembio.5b01053 · Cited by 28
Morphology control of self-deliverable nanodrug with enhanced anticancer efficiency
Qin, S., Cheng, Y., Jiang, Z., Ma, Y., & Zhang, A. (2018) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2018.02.054 · Cited by 20
Self-citation
Cited by
Recent progress in nanomedicine for enhanced cancer chemotherapy
Wei, G., Wang, Y., Yang, G., Wang, Y., & Ju, R. (2021) · Theranostics · doi:10.7150/thno.57828 · Cited by 463
A Review on Nano-Based Drug Delivery System for Cancer Chemoimmunotherapy
Mu, W., Chu, Q., Liu, Y., & Zhang, N. (2020) · Nano-Micro Letters · doi:10.1007/s40820-020-00482-6 · Cited by 328
Controlling the biodistribution and clearance of nanomedicines
Cabral, H., Li, J., Miyata, K., & Kataoka, K. (2023) · Nature Reviews Bioengineering · doi:10.1038/s44222-023-00138-1 · Cited by 303
Status and Challenges of Plant-Anticancer Compounds in Cancer Treatment
Garcia-Oliveira, P., Otero, P., Pereira, A. G., Chamorro, F., Carpena, M., Echave, J., Fraga-Corral, M., Simal-Gandara, J., & Prieto, M. A. (2021) · Pharmaceuticals · doi:10.3390/ph14020157 · Cited by 303
Characterization and anti-tumor bioactivity of astragalus polysaccharides by immunomodulation
Li, W., Hu, X., Wang, S., Jiao, Z., Sun, T., Liu, T., & Song, K. (2020) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2019.09.189 · Cited by 277
Metadata
- Authors
- Qin, S.-Y., Cheng, Y.-J., Lei, Q., Zhang, A.-Q., & Zhang, X.-Z.
- Venue
- Biomaterials
- Publisher
- Elsevier BV
- Published
- 2018-07
- Volume
- 171
- Pages
- 178-197
- ISSN
- 0142-9612 (ISSN-L)
- OpenAlex
- W2802126705
- Cited by
- 301
- References
- 193
- FWCI
- 9.25
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.